Literature DB >> 24625325

Methylenetetrahydrofolate reductase polymorphisms in myelodysplastic syndromes and therapy-related myeloid neoplasms.

Marianna Criscuolo1, Patrizia Chiusolo, Sabrina Giammarco, Manuela Giachelia, Luana Fianchi, Emiliano Fabiani, Giulia Falconi, Stefan Hohaus, Simona Sica, Giuseppe Leone, Maria Teresa Voso.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24625325     DOI： 10.3109/10428194.2014.903475

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  3 in total

Review 1.  Why methylation is not a marker predictive of response to hypomethylating agents.

Authors:  Maria Teresa Voso; Valeria Santini; Emiliano Fabiani; Luana Fianchi; Marianna Criscuolo; Giulia Falconi; Francesco Guidi; Stefan Hohaus; Giuseppe Leone
Journal:  Haematologica       Date:  2014-04       Impact factor: 9.941

Review 2.  From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms: The Silent Way of Cancer Progression.

Authors:  Carmelo Gurnari; Emiliano Fabiani; Giulia Falconi; Serena Travaglini; Tiziana Ottone; Antonio Cristiano; Maria Teresa Voso
Journal:  Biology (Basel)       Date:  2021-02-06

Review 3.  Therapy-related myeloid neoplasms: clinical perspectives.

Authors:  Luana Fianchi; Marianna Criscuolo; Emiliano Fabiani; Giulia Falconi; Alessio Maria Edoardo Maraglino; Maria Teresa Voso; Livio Pagano
Journal:  Onco Targets Ther       Date:  2018-09-17       Impact factor: 4.147
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.